Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about 30,000 people are diagnosed with mesothelioma each year.
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the advanced stages of the disease still requires more precise tools. Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have now tested a novel approach.
An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.
An analysis of the brain of a deceased Alzheimer’s disease (AD) clinical trial participant found that regions where an anti-amyloid therapy successfully cleared amyloid plaques showed little to no evidence of tau tangles, a hallmark of AD closely linked to neurodegeneration and cognitive decline.
With the aid of physical forces—in this case, sound—it is possible to actively steer the formation of engineered tissue. For example, sound waves can be used to create functional vascular networks with blood vessel-like structures in vitro. Scientists at the Center for Molecular Biology of Heidelberg University have demonstrated this through their methodology for acoustic manipulation. The team led by Junior Professor Dr. Daniela Duarte Campos also defines quality requirements for generating complex vascularized 3D tissue containing multiple cell types that is relevant, for example, to biomedical studies.
More than 100,000 people in the United States are waiting for a lifesaving organ transplant. For patients who need a liver transplant, determining whether a donor liver is healthy enough to transplant is a critical part of the process.
A breakthrough combination of new silicone materials and advanced 3D printing technology developed by University of Waterloo researchers could transform how contact lenses are manufactured.
Automated software helps respiratory therapists identify ineffective efforts, the most frequent type of patient-ventilator asynchrony in mechanically ventilated patients
B. Braun Medical Inc. announced the FDA approval of Sugammadex Injection, 200 mg/2 mL (100 mg/mL), AP-rated generic BRIDION®1* (Sugammadex Injection) in the U.S. market.
Newronika announced today that it secured CE mark for its latest adaptive deep brain stimulation (aDBS) system.